News Center
News Center

News Center

With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.

Corporate News

Staff Style

24

2024

-

10

Xi Bao | Warm Congratulations to Yinuo Pharmaceuticals®fluoxetine hydrochloride dispersible tablets glory on the list of "2024 jinan innovative industrial products" list!

Classification：

News

行业新闻

Corporate News

 

 

 

 

Last article

Xi Bao | Transformation and Upgrade of Digital Intelligence! Warmly celebrate the selection of Linuo Pharmaceutical into the DCMM pilot enterprise in Shandong Province!

Next article

Building a Learning Team (Lesson 6) | lino pharmaceutical held financial knowledge and lean digital intelligence management training to promote endogenous motivation!

Related news

The Chairman of Keyuan Pharmaceutical was invited to attend the Third Global Go‑Global Summit, where they jointly explored new pathways for the pharmaceutical industry’s international expansion.

The Chairman of Keyuan Pharmaceutical was invited to attend the Third Global Go‑Global Summit, where they jointly explored new pathways for the pharmaceutical industry’s international expansion.

2026-06-29

Linuo Pharmaceutical unveils its 2026 Starry Night Summit, with a glorious coronation that underscores its formidable strength!

Linuo Pharmaceutical unveils its 2026 Starry Night Summit, with a glorious coronation that underscores its formidable strength!

2026-06-16

Deep Affection on the Dragon Boat Festival, Zongzi Aroma Fills the Courtyard | Linuo Pharmaceutical Warmly Hosts a Special Dragon Boat Festival Event

Deep Affection on the Dragon Boat Festival, Zongzi Aroma Fills the Courtyard | Linuo Pharmaceutical Warmly Hosts a Special Dragon Boat Festival Event

2026-06-22

Renowned financial writer Wu Xiaobo visited Keyuan Pharmaceutical, praising the company’s achievements in digital and intelligent transformation.

Renowned financial writer Wu Xiaobo visited Keyuan Pharmaceutical, praising the company’s achievements in digital and intelligent transformation.

2026-05-18

On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.